Accellacare’s Post

View organization page for Accellacare, graphic

3,802 followers

Accellacare offers experience in phase II-IV obesity studies involving most major drug classes including: GLP-1 receptor agonist, SGLT-2 inhibitors, DP-4 Inhibitors, Insulin and Insulin Analogs, and Alpha Glucosidase Inhibitors just to name a few. Learn more about our experience: https://ow.ly/BXOO50SIZS1

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics